AnalytiCon Discovery and Pharvaris extend their collaboration

2 February 2022, Potsdam (Germany) - AnalytiCon Discovery, a first-class provider of natural product, drug discovery and development services, today announced the extension of their research and development collaboration with Pharvaris, a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonist small molecules to patients.